Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Gurrin
PDB26 Evidence Requirements in Australia for Drug Reimbursement: The Survival of Cost Minimisation Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P5-S3.04 Continued Decline in Genital Warts 3 Years After Introduction of Quadrivalent Human Papillomavirus (HPV) Vaccination Program
Sexually Transmitted Infections
Dermatology
Infectious Diseases
Related publications
Cost Minimisation Analysis of Provision of Oxygen at Home: Are the Drug Tariff Guidelines Cost Effective?
BMJ
Costs and Cost-Minimisation Analysis.
BMJ
Lessons for Adaptive Licensing: Analysis of Conditionally Approved EMA Compounds, Their Reimbursement Status and Regulatory/Reimbursement Data Requirements
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Centers for Medicare & Medicaid Services’ Decision on Drug-Coated Balloons: No Additional Reimbursement Despite Higher Cost and Highest Levels of Scientific Evidence
Vascular Medicine
Medicine
Cardiovascular Medicine
Cardiology
Cost Minimisation of Product Transhipment for Physical Distribution Management
Journal of Transport and Supply Chain Management
Management
Transportation
Manufacturing Engineering
Management Science
Industrial
Management Information Systems
Information Systems
Operations Research
Divergent Evidence Requirements Comparing the Authorization and Reimbursement Processes of High-Risk Medical Devices – The European Situation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Economic Evaluation and Cost-Effectiveness Threshold in Practice of Decision-Making on Orphan Drug Reimbursement in Poland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost Analysis of Rapid Diagnostics for Drug-Resistant Tuberculosis
BMC Infectious Diseases
Infectious Diseases
The Barriers to Reimbursement Success for Non-Small Cell Lung Cancer Therapies in Australia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
